PATIENT INFORMATION
Pregnancy: Female patients of childbearing age
should be told about the consequences of second-and third-trimester
exposure to drugs that act on the renin-angiotensin system,
and they should also be told that these consequences do
not appear to have resulted from intrauterine drug exposure
that has been limited to the first trimester. These patients
should be asked to report pregnancies to their physicians
as soon as possible.
See also WARNINGS, CONTRAINDICATIONS,
and PRECAUTIONS.
|
|
